Cargando…

A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m(6)A Modification to Blood Biomarkers

With recent advancements in biological research, long non-coding RNAs (lncRNAs) with lengths exceeding 200 nucleotides have emerged as pivotal regulators of gene expression and cellular phenotypic modulation. Despite initial skepticism due to their low sequence conservation and expression levels, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eun, Jung Woo, Cheong, Jae Youn, Jeong, Jee-Yeong, Kim, Hyung Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528438/ https://www.ncbi.nlm.nih.gov/pubmed/37759495 http://dx.doi.org/10.3390/cells12182272

Ejemplares similares

Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma
por: Kim, Hyung Seok, et al.
Publicado: (2023)

Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
por: Son, Ju A, et al.
Publicado: (2022)

Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues
por: Meng, Qingren, et al.
Publicado: (2023)

Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment
por: Si, Chaohua, et al.
Publicado: (2021)

Identification of long non-coding RNA-related and –coexpressed mRNA biomarkers for hepatocellular carcinoma
por: Zhang, Fan, et al.
Publicado: (2019)

Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma
por: Cho, Hyo Jung, et al.
Publicado: (2020)

Increased HOXC6 mRNA expression is a novel biomarker of gastric cancer
por: Jung, Jiyoon, et al.
Publicado: (2020)

Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma
por: Cho, Hyo Jung, et al.
Publicado: (2020)

Diagnostic Blood Biomarkers in Alzheimer’s Disease
por: Park, Jung Eun, et al.
Publicado: (2022)

m6A Modification in Non-Coding RNA: The Role in Cancer Drug Resistance
por: Chen, Chen, et al.
Publicado: (2021)

Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets
por: Chen, Da-Hong, et al.
Publicado: (2021)

Advances in understanding red blood cell modifications by Babesia
por: Hakimi, Hassan, et al.
Publicado: (2022)

Two DNA Methyltransferases for Site-Specific 6mA and 5mC DNA Modification in Xanthomonas euvesicatoria
por: Park, Hye-Jee, et al.
Publicado: (2021)

Clinical Utility of Plasma Glypican-3 and Osteopontin as Biomarkers of Hepatocellular Carcinoma
por: Lee, Hyun Jung, et al.
Publicado: (2014)

The comprehensive expression and functional analysis of m6A modification “readers” in hepatocellular carcinoma
por: Qin, Sha, et al.
Publicado: (2022)

Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma
por: Eun, Jung Woo, et al.
Publicado: (2023)

ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m(6)A modification, and drug susceptibility
por: Ding, Yongqi, et al.
Publicado: (2023)

Predicting amyloid PET positivity using plasma p‐tau181 and other blood‐based biomarkers
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Novel insights into m(6)A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance
por: Jia, Jinlin, et al.
Publicado: (2022)

Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma
por: Son, Ju A, et al.
Publicado: (2023)

Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Cho, Hyo-Jung, et al.
Publicado: (2021)

GNAQ-Regulated ZO-1 and ZO-2 Act as Tumor Suppressors by Modulating EMT Potential and Tumor-Repressive Microenvironment in Lung Cancer
por: Kim, Hyung Seok, et al.
Publicado: (2023)

Pinin Induces Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma by Regulating m6A Modification
por: Qiao, Kailiang, et al.
Publicado: (2021)

Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report
por: Han, Ji Eun, et al.
Publicado: (2021)

Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma
por: Chen, Tingsong
Publicado: (2022)

Prognostic Value of Erythroblastic Leukemia Viral Oncogene Homolog 2 and Neuregulin 4 in Hepatocellular Carcinoma
por: Rou, Woo Sun, et al.
Publicado: (2023)

Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs
por: Harsanyi, Stefan, et al.
Publicado: (2022)

Crosstalk between RNA m(6)A Modification and Non-coding RNA Contributes to Cancer Growth and Progression
por: Dai, Fengsheng, et al.
Publicado: (2020)

The emerging role of m(6)A modification of non-coding RNA in gastrointestinal cancers: a comprehensive review
por: Wang, Meiqi, et al.
Publicado: (2023)

Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma
por: Zhang, Lele, et al.
Publicado: (2020)

M6A regulator-mediated immune infiltration and methylation modification in hepatocellular carcinoma microenvironment and immunotherapy
por: Zhao, Kun, et al.
Publicado: (2022)

Genetic Code Expansion: A Powerful Tool for Understanding the Physiological Consequences of Oxidative Stress Protein Modifications
por: Porter, Joseph J., et al.
Publicado: (2018)

KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA
por: Cheng, Xiaoyu, et al.
Publicado: (2019)

N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma
por: Yang, Kun, et al.
Publicado: (2022)

Recent Evolution of Surgical Treatment for Gastric Cancer in Korea
por: An, Ji Yeong, et al.
Publicado: (2011)

Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma
por: Sun, Li, et al.
Publicado: (2018)

Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2019)

Clinical Significance of the Prognostic Nutritional Index for Predicting Short- and Long-Term Surgical Outcomes After Gastrectomy: A Retrospective Analysis of 7781 Gastric Cancer Patients
por: Lee, Jee Youn, et al.
Publicado: (2016)

Identification and experimental validation of key m6A modification regulators as potential biomarkers of osteoporosis
por: Qiao, Yanchun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u0tu6lp5tcbe3ce4h3t2l0sein